Skip to main content

Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 526–540 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-3655
OAT Gene Gyrate Atrophy of Choroid and Retina Genetic Test

This genetic test identifies pathogenic variants in the OAT gene, confirming a diagnosis of gyrate atrophy of the choroid and retina.

Whole Blood (EDTA), Extracted DNA, or FTA Card 3-4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the OAT gene", "Single nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy number variations (CNV)"]
Parameters
[]
Preparation
["No fasting required", "Do not discontinue or modify prescribed medications, including low-protein diets or pyridoxine (Vitamin B6) supplementation, without consulting your physician"]
Indications
["Suspected gyrate atrophy based on clinical signs", "Family history of gyrate atrophy", "Carrier screening", "Family planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101281-1 ICD-10: H31.22
Clinical summary
This genetic test identifies pathogenic variants in the OAT gene, confirming a diagnosis of gyrate atrophy of the choroid and retina.
TEST-3056
OCLN Gene (Band‑like Calcification with Simplified Gyration and Polymicrogyria) Genetic Test

This test identifies pathogenic variants in the OCLN gene associated with band-like calcification with simplified gyration and polymicrogyria (BLC-PMG).

Whole Blood (EDTA), Extracted DNA, or FTA Card 3–4 weeks from sample receipt 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the OCLN gene", "Copy Number Variants (CNVs) within the OCLN gene"]
Parameters
[]
Preparation
["No drug or supplement cessation is required.", "Continue all prescribed medications unless otherwise instructed by your attending physician."]
Indications
["Suspected diagnosis of band-like calcification with simplified gyration and polymicrogyria (BLC-PMG)", "Family history of BLC-PMG"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94473-2 ICD-10: Q04.8
Clinical summary
This test identifies pathogenic variants in the OCLN gene associated with band-like calcification with simplified gyration and polymicrogyria (BLC-PMG).
TEST-4152
OCRL Gene Dent Disease Type 2 Genetic Test

This test evaluates the OCRL gene for pathogenic variants associated with X-linked Dent disease type 2.

Whole Blood, Extracted DNA, or FTA Card Blood Spot 3 – 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the OCRL gene", "Single nucleotide variants", "Small insertions/deletions", "Exon-level copy number changes"]
Parameters
[]
Preparation
["No special physical preparation is needed for the blood draw.", "Bring a list of all current medications to the counselling session."]
Indications
["Suspected Dent disease type 2 based on clinical presentation", "Family history of Dent disease type 2", "Need for definitive genetic diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 60777-8 ICD-10: N25.89, N15.1
Clinical summary
This test evaluates the OCRL gene for pathogenic variants associated with X-linked Dent disease type 2.
TEST-4846
OCRL Gene Sequencing Test for Lowe Oculocerebrorenal Syndrome

This test evaluates the entire OCRL gene for pathogenic variants associated with Lowe oculocerebrorenal syndrome.

Whole Blood (Peripheral) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the OCRL gene", "Exons and splice sites of the OCRL gene"]
Parameters
[]
Preparation
["No special preparation needed", "Prior genetic counseling is advised"]
Indications
["Suspected Lowe oculocerebrorenal syndrome based on clinical features", "Family history of Lowe syndrome"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 55217-9 ICD-10: Q87.89
Clinical summary
This test evaluates the entire OCRL gene for pathogenic variants associated with Lowe oculocerebrorenal syndrome.
TEST-6028
OPA3 Gene (3-Methylglutaconic Aciduria Type III) Genetic Test

This genetic test analyzes the OPA3 gene to identify mutations causing 3-Methylglutaconic Aciduria Type III (Costeff syndrome). It provides a definitive diagnosis by detecting path...

Whole blood, extracted DNA, or FTA card 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the OPA3 gene", "Presence of mutations associated with 3-Methylglutaconic Aciduria Type III"]
Parameters
[]
Preparation
["No specific fasting required for blood draw", "Inform the phlebotomist of any medications being taken"]
Indications
["Individuals with clinical features suggestive of 3-Methylglutaconic Aciduria Type III", "Carrier screening for family members of affected individuals", "Prenatal diagnosis in high-risk pregnancies", "Confirmation of diagnosis after abnormal biochemical screening"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94222-1 ICD-10: E71.11
Clinical summary
This genetic test analyzes the OPA3 gene to identify mutations causing 3-Methylglutaconic Aciduria Type III (Costeff syndrome). It provides a definitive diagnosis by detecting pathogenic variants.
TEST-2604
ORC4 Gene Meier-Gorlin Syndrome Type 2 Genetic Test

This test identifies pathogenic variants in the ORC4 gene, which are associated with Meier-Gorlin syndrome type 2, a rare form of primordial dwarfism.

Whole Blood, Extracted DNA, or One-Drop Blood on FTA Card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ORC4 gene", "Single-nucleotide variants", "Small insertions", "Small deletions"]
Parameters
[]
Preparation
["No special fasting required", "No medication changes required"]
Indications
["Clinical suspicion of Meier-Gorlin syndrome type 2", "Presence of characteristic features like microtia, patellar anomalies, and short stature"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82007-5 ICD-10: Q87.1
Clinical summary
This test identifies pathogenic variants in the ORC4 gene, which are associated with Meier-Gorlin syndrome type 2, a rare form of primordial dwarfism.
TEST-4691
OSTM1 Gene Osteopetrosis, Autosomal Recessive Type 5 Genetic Test

This diagnostic test evaluates the OSTM1 gene for pathogenic variants associated with autosomal recessive osteopetrosis type 5.

Peripheral Whole Blood or FTA Card Blood Spot 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the OSTM1 gene", "Coding region and splice sites of the OSTM1 gene"]
Parameters
[]
Preparation
["Genetic counseling session mandatory before sample collection", "Do not discontinue prescribed medication without consulting your doctor"]
Indications
["Clinical suspicion of autosomal recessive osteopetrosis type 5", "Family history of osteopetrosis", "Need for carrier screening in family members", "Guiding treatment decisions (e.g., hematopoietic stem cell transplantation)"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93733-7 ICD-10: Q78.2, Z15.89, D81.9
Clinical summary
This diagnostic test evaluates the OSTM1 gene for pathogenic variants associated with autosomal recessive osteopetrosis type 5.
TEST-5813
OXCT1 Gene (Succinyl-CoA:3-Oxoacid CoA Transferase Deficiency) Genetic Test

This genetic test identifies pathogenic variants in the OXCT1 gene associated with Succinyl-CoA:3-Oxoacid CoA Transferase (SCOT) deficiency.

Whole blood, extracted DNA, or FTA card blood spot 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the OXCT1 gene", "Single-nucleotide variants", "Copy number changes"]
Parameters
[]
Preparation
["Pre-test genetic counseling session required", "Do not perform elective blood draw during acute metabolic crisis", "Stabilize patient before specimen collection if in crisis"]
Indications
["Recurrent unexplained ketoacidosis", "Family history of SCOT deficiency", "Consanguineous backgrounds (Emirati, South Asian heritage)", "Pre-test genetic counseling documentation"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 79474-8 ICD-10: E88.8, Z13.228, Z15.89
Clinical summary
This genetic test identifies pathogenic variants in the OXCT1 gene associated with Succinyl-CoA:3-Oxoacid CoA Transferase (SCOT) deficiency.
TEST-3312
P2RY12 Gene Platelet‑Type 8 Bleeding Disorder DNA Test

This test evaluates the P2RY12 gene for pathogenic variants associated with platelet-type 8 bleeding disorder.

Whole Blood, Extracted DNA, or FTA Card Blood Spot 14–21 Business Days 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the P2RY12 gene"]
Parameters
[]
Preparation
["No fasting required", "Genetic counseling session advised beforehand"]
Indications
["Suspected inherited platelet disorder", "Family history of bleeding disorders", "Evaluation of platelet dysfunction"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92940-1 ICD-10: D69.1
Clinical summary
This test evaluates the P2RY12 gene for pathogenic variants associated with platelet-type 8 bleeding disorder.
TEST-5890
PAH Gene Phenylketonuria (PKU) Genetic Test

This test evaluates the PAH gene for pathogenic variants associated with phenylketonuria (PKU) and hyperphenylalaninemia.

Whole blood, extracted DNA, or FTA card 3 to 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["PAH gene sequence", "Pathogenic variants in PAH gene"]
Parameters
[]
Preparation
["None specified"]
Indications
["Suspected PKU", "Family history of PKU", "Carrier screening", "Family planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: E70.0
Clinical summary
This test evaluates the PAH gene for pathogenic variants associated with phenylketonuria (PKU) and hyperphenylalaninemia.
TEST-4601
PARN Gene Pulmonary Fibrosis and Bone Marrow Failure, Telomere-Related Type 4 Genetic Test

This test identifies pathogenic variants in the PARN gene associated with telomere-related pulmonary fibrosis and bone marrow failure.

Peripheral Whole Blood, DNA extraction card, or extracted DNA 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the PARN gene", "Telomere biology related genetic risk"]
Parameters
[]
Preparation
["Pre-test genetic counselling session is mandatory", "Informed consent required"]
Indications
["Suspected hereditary telomere biology disorder", "Family history of pulmonary fibrosis or bone marrow failure", "Guidance for surveillance and family planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21670-8 ICD-10: J84.10, D61.9
Clinical summary
This test identifies pathogenic variants in the PARN gene associated with telomere-related pulmonary fibrosis and bone marrow failure.
TEST-3572
PAX6 Gene Coloboma of the Optic Nerve Genetic Test

This test evaluates the PAX6 gene for pathogenic variants associated with congenital optic nerve coloboma using next-generation sequencing.

Peripheral Whole Blood (EDTA), Saliva (FTA Card), or Extracted Genomic DNA 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["PAX6 gene sequence variants (SNVs, indels)", "PAX6 gene copy-number variants (exon-level deletions/duplications)"]
Parameters
[]
Preparation
["No fasting required", "Pre-test genetic counseling with a detailed three-generation pedigree is mandatory"]
Indications
["Diagnosis of congenital optic nerve coloboma", "Genetic counseling for families with affected individuals", "Surveillance planning for associated systemic features"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94495-7 ICD-10: Q14.2, H47.31
Clinical summary
This test evaluates the PAX6 gene for pathogenic variants associated with congenital optic nerve coloboma using next-generation sequencing.
TEST-3631
PAX6 Gene Foveal Hypoplasia Type 1 Genetic Test

This genetic test identifies mutations within the PAX6 gene associated with congenital foveal hypoplasia and aniridia.

Whole Blood or Dried Blood Spot (FTA Card) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["PAX6 gene mutations", "Copy Number Variations (CNVs) in PAX6 gene"]
Parameters
[]
Preparation
["No specific fasting required", "Do not discontinue prescribed medication"]
Indications
["Confirmation of clinical diagnosis", "Guiding prognosis", "Family risk assessment"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93296-9 ICD-10: Q14.1, Q13.1
Clinical summary
This genetic test identifies mutations within the PAX6 gene associated with congenital foveal hypoplasia and aniridia.
TEST-6150
PCBD1 Gene Hyperphenylalaninemia, BH4-Deficient, Type D Genetic Test

This test analyzes the PCBD1 gene for pathogenic variants causing BH4-deficient hyperphenylalaninemia type D.

Whole blood, extracted DNA, or dried blood spot (FTA card) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["PCBD1 gene pathogenic variants", "Tetrahydrobiopterin synthesis disruption"]
Parameters
[]
Preparation
["No fasting necessary"]
Indications
["Diagnosis of BH4-deficient hyperphenylalaninemia type D", "Individuals with elevated phenylalanine levels", "Family history of biopterin synthesis disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 48018-6 ICD-10: E70.1
Clinical summary
This test analyzes the PCBD1 gene for pathogenic variants causing BH4-deficient hyperphenylalaninemia type D.
TEST-4294
PCDH19 Gene Early Infantile Epileptic Encephalopathy Type 9 Genetic Test

This genetic test evaluates the PCDH19 gene for mutations associated with Early Infantile Epileptic Encephalopathy Type 9 (EIEE9).

Peripheral Blood (Whole Blood) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["PCDH19 gene mutations", "Point mutations", "Small insertions", "Small deletions"]
Parameters
[]
Preparation
[]
Indications
["Suspected Early Infantile Epileptic Encephalopathy Type 9 (EIEE9)", "Diagnosis of severe neurodevelopmental disorder with seizures"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81307-0 ICD-10: G40.89
Clinical summary
This genetic test evaluates the PCDH19 gene for mutations associated with Early Infantile Epileptic Encephalopathy Type 9 (EIEE9).

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.